Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Gut Microbiota in Inflammatory Bowel Disease

  • Shim, Jung Ok (Department of Pediatrics, Korea University College of Medicine)
  • Received : 2013.03.14
  • Accepted : 2013.03.20
  • Published : 2013.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

The gut mucosal barrier plays an important role in maintaining a delicate immune homeostasis. The pathogenesis of inflammatory bowel disease (IBD) is considered to involve a defective mucosal immunity along with a genetic predisposition. Recent views have suggested an excessive response to components of the gut microbiota in IBD. A condition of "dysbiosis", with alterations of the gut microbial composition, has been observed in patients with IBD. In this article, the author review recent studies of gut microbiota in IBD, particularly the importance of the gut microbiota in the pathogenesis of pediatric IBD.

Keywords

References

  1. Seo JK. Pediatric inflammatory bowel disease (IBD): Phenotypic, genetic and therapeutic differences between early-onset and adult-onset IBD. Korean J Pediatr Gastroenterol Nutr 2011;14:1-25. https://doi.org/10.5223/kjpgn.2011.14.1.1
  2. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-64. https://doi.org/10.1084/jem.180.6.2359
  3. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011;140:1729-37. https://doi.org/10.1053/j.gastro.2011.02.012
  4. Aldhous MC. Gene-environmental interactions in inflammatory bowel disease: microbiota and genes. Frontline Gastroenterology 2012;3:180-6. https://doi.org/10.1136/flgastro-2011-100097
  5. Thomazini CM, Samegima DA, Rodrigues MA, Victoria CR, Rodrigues J. High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases. Int J Med Microbiol 2011;301:475-9. https://doi.org/10.1016/j.ijmm.2011.04.015
  6. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010;12:99-113. https://doi.org/10.1111/j.1462-5822.2009.01381.x
  7. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-70. https://doi.org/10.1084/jem.192.4.565
  8. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205-11. https://doi.org/10.1136/gut.2005.073817
  9. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52:237-42. https://doi.org/10.1136/gut.52.2.237
  10. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010;139:1844-54.e1. https://doi.org/10.1053/j.gastro.2010.08.049
  11. Hammer HF. Gut microbiota and inflammatory bowel disease. Dig Dis 2011;29:550-3. https://doi.org/10.1159/000332981
  12. Iebba V, Aloi M, Civitelli F, Cucchiara S. Gut microbiota and pediatric disease. Dig Dis 2011;29:531-9. https://doi.org/10.1159/000332969
  13. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54. https://doi.org/10.1053/gast.2002.30294
  14. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1720-8. https://doi.org/10.1053/j.gastro.2011.01.054
  15. Negroni A, Costanzo M, Vitali R, Superti F, Bertuccini L, Tinari A, et al. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2012;18:913-24. https://doi.org/10.1002/ibd.21899
  16. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007;104:13780-5. https://doi.org/10.1073/pnas.0706625104
  17. Nagalingam NA, Lynch SV. Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18:968-84. https://doi.org/10.1002/ibd.21866
  18. Meyer AM, Ramzan NN, Loftus EV Jr, Heigh RI, Leighton JA. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004;38:772-5. https://doi.org/10.1097/01.mcg.0000139057.05297.d6
  19. Michail S, Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J, et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis 2012;18:1799-808. https://doi.org/10.1002/ibd.22860
  20. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603. https://doi.org/10.1038/35079107
  21. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011;474:298-306. https://doi.org/10.1038/nature10208
  22. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:179-84. https://doi.org/10.1002/ibd.21339
  23. Brant SR, Wang MH, Rawsthorne P, Sargent M, Datta LW, Nouvet F, et al. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis. Am J Gastroenterol 2007;102:313-23. https://doi.org/10.1111/j.1572-0241.2006.00926.x
  24. Landy J, Al-Hassi HO, McLaughlin SD, Walker AW, Ciclitira PJ, Nicholls RJ, et al. Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther 2011;34:409-15. https://doi.org/10.1111/j.1365-2036.2011.04737.x

Cited by

  1. The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood vol.76, pp.1, 2013, https://doi.org/10.1038/pr.2014.49
  2. Smoking- and alcohol habits in relation to the clinical picture of women with microscopic colitis compared to controls vol.14, pp.1, 2013, https://doi.org/10.1186/1472-6874-14-16
  3. Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn’s disease vol.14, pp.None, 2013, https://doi.org/10.1186/s12876-014-0190-1
  4. The Intestinal Microbiome in Early Life: Health and Disease vol.5, pp.None, 2014, https://doi.org/10.3389/fimmu.2014.00427
  5. Conventional Housing Conditions Attenuate the Development of Experimental Autoimmune Encephalomyelitis vol.9, pp.6, 2013, https://doi.org/10.1371/journal.pone.0099794
  6. Oral administration of Lactobacillus paracasei alleviates clinical symptoms of colitis induced by dextran sulphate sodium salt in BALB/c mice vol.5, pp.3, 2013, https://doi.org/10.3920/bm2013.0041
  7. Anti-TNF-α treatment for post-anastomotic ulcers and inflammatory bowel disease with Crohn’s-like pathologic changes following intestinal surgery in pediatric patients vol.31, pp.1, 2013, https://doi.org/10.1007/s00383-014-3633-4
  8. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology vol.2015, pp.None, 2015, https://doi.org/10.1155/2015/489821
  9. New insights and challenges in microscopic colitis vol.8, pp.1, 2013, https://doi.org/10.1177/1756283x14550134
  10. Intestinal Microbiota, Microbial Translocation, and Systemic Inflammation in Chronic HIV Infection vol.211, pp.1, 2015, https://doi.org/10.1093/infdis/jiu409
  11. Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice vol.10, pp.7, 2015, https://doi.org/10.1371/journal.pone.0126976
  12. Human microbiome versus food-borne pathogens: friend or foe vol.100, pp.11, 2016, https://doi.org/10.1007/s00253-016-7523-7
  13. Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition vol.5, pp.7, 2013, https://doi.org/10.1080/2162402x.2016.1164918
  14. Inflammatory Bowel Disease: How Effective Is TNF-α Suppression? vol.11, pp.11, 2013, https://doi.org/10.1371/journal.pone.0165782
  15. Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice vol.8, pp.None, 2013, https://doi.org/10.3389/fimmu.2017.00397
  16. Human Gut Microbiota: Toward an Ecology of Disease vol.8, pp.None, 2017, https://doi.org/10.3389/fmicb.2017.01265
  17. Assessment of fecal microbiota in farmed silver fox (Vulpes vulpes fulva) and raccoon dog (Nyctereutes procyonoides) vol.68, pp.3, 2013, https://doi.org/10.1080/09064702.2019.1637451
  18. Pituitary Adenylate Cyclase-Activating Polypeptide—A Neuropeptide as Novel Treatment Option for Subacute Ileitis in Mice Harboring a Human Gut Microbiota vol.10, pp.None, 2019, https://doi.org/10.3389/fimmu.2019.00554
  19. High-throughput sequencing reveals the core gut microbiota of the mud crab (Scylla paramamosain) in different coastal regions of southern China vol.20, pp.1, 2013, https://doi.org/10.1186/s12864-019-6219-7
  20. Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease vol.12, pp.None, 2013, https://doi.org/10.3389/fphys.2021.783295
  21. Influence of Fluconazole Administration on Gut Microbiome, Intestinal Barrier, and Immune Response in Mice vol.65, pp.6, 2021, https://doi.org/10.1128/aac.02552-20